Acute upper respiratory infection
Information
- Disease name
- Acute upper respiratory infection
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT06457269 | Completed | N/A | Evaluating the Potential of Large Language Models for Respiratory Disease Consultations | October 1, 2023 | April 4, 2024 |
| NCT01779271 | Completed | Phase 3 | Phase 3 Study of Pelubiprofen & Loxoprofen in Patients With Upper Respiratory Tract Infection | January 2013 | |
| NCT02622659 | Completed | Phase 4 | The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Influenza (Acute Upper Respiratory Infection) | March 2012 | March 2014 |
| NCT02654158 | Completed | Phase IV Trial,The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Acute Upper Respiratory Infection | August 2013 | May 2017 | |
| NCT02983019 | Completed | Treatment of Influenza in Routine Clinical Practice | December 2013 | September 2016 | |
| NCT04651491 | Completed | Treatment of Influenza and ARVI in Children by Kagocel ® | September 11, 2015 | September 28, 2016 | |
| NCT02539277 | Unknown status | Phase 4 | A Post-marketing Research on Jinyebaidu Granule in Treating Patients With Acute Upper Respiratory Infection | December 2014 | November 2015 |
| NCT01694329 | Unknown status | Impact of Introduction of PHiD-CV for Nunavik Children, Quebec, Canada | September 2012 | December 31, 2017 | |
| NCT04252963 | Unknown status | Phase 4 | Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(Streptokinase • Streptodornase) | November 2, 2018 | May 2021 |
| NCT01814293 | Withdrawn | N/A | Comparison of Supportive Therapies for Symptom Relief From Pediatric Upper Respiratory Infections (URIs) | May 2013 | September 2013 |